North Korean Lazarus Group Linked to Medusa Ransomware Attacks
North Korean state‑backed Lazarus group has been linked to recent Medusa ransomware attacks targeting U.S. healthcare providers. Symantec’s report identifies a Lazarus sub‑unit, possibly Andariel/Stonefly, using the Medusa RaaS platform, which has affected more than 380 organizations since its 2021 debut. The ransomware demands average $260,000, with some extortion requests reaching $15 million, and the proceeds are funneled into espionage operations against defense, technology and government entities. The attacks also incorporate tools associated with the Diamond Sleet group and a range of commodity malware.
FDA Accepts Beren Therapeutics’ NDA for Niemann-Pick Disease
Beren Therapeutics announced that the U.S. Food and Drug Administration has accepted its New Drug Application for adrabetadex, an investigational therapy aimed at treating infantile‑onset Niemann‑Pick disease type C (NPC). The agency set a target action date of 17 August 2026 under the...
STAT+: New Treatment Approach Could Give IBD Patients Hope, and Be a Bonanza for Drugmakers
A new combination‑therapy approach for inflammatory bowel disease (IBD) aims to boost remission rates beyond the current 30 % success benchmark. By pairing agents that target distinct immune pathways, early trials show remission climbing to roughly 55 % and faster mucosal healing....
Advancing Pediatric MASLD Screening: Challenges and Future
A forthcoming Pediatric Research review by Vimalesvaran and Dhawan examines the current state of Metabolic Dysfunction‑associated Steatotic Liver Disease (MASLD) screening in children, highlighting advances in imaging and biomarker research while exposing persistent gaps in sensitivity and guideline standardization. The...
GSMA Foundry and NUHS Singapore to Drive 5G and AI Innovations in Healthcare Through New Strategic Partnership
GSMA Foundry has signed a strategic partnership with Singapore’s National University Health System (NUHS) to accelerate 5G‑enabled, AI‑driven healthcare solutions. The collaboration will leverage private 5G networks, digital twins, XR, IoT and ambient AI to enable remote surgical assistance, immersive...
Comparing Senescence in Articular Chondrocytes: Phenotype & Molecules
Researchers published a comparative analysis of replicative versus chemically‑induced senescence in articular chondrocytes, revealing divergent molecular signatures, secretory profiles, and mitochondrial dynamics. Replicative senescence displayed a controlled, anti‑inflammatory SASP and stable epigenetic marks, while chemically‑induced senescence produced a pro‑inflammatory secretome,...
b.well Connected Health Unveils Bailey™
b.well Connected Health launched bailey™, a white‑label AI health assistant that can be embedded into an organization’s existing apps in weeks. Powered by b.well’s Health AI SDK and a 13‑step data refinery, bailey accesses a longitudinal health record compiled from...
Where MENA CIOs Draw the Line on AI Sovereignty
MENA CIOs are drawing firm lines around AI sovereignty, keeping regulated workloads—such as patient data, identity systems, and core financial transactions—on sovereign or on‑premise infrastructure while leveraging hyperscalers for development, testing, and non‑sensitive analytics. The hybrid approach reflects regional regulatory...
New Research Reveals Dry Powder Inhalers Enhance Patient Outcomes and Reduce Environmental Impact
UCLA Health researchers published a JAMA Internal Medicine study showing that dry powder inhalers (DPIs) and soft‑mist inhalers (SMIs) cut COPD exacerbations while eliminating high‑global‑warming‑potential propellants used in metered‑dose inhalers (MDIs). The analysis of insurance‑claims data from 2016‑2025 found a...
Hims Reports 2025 Earnings, Shares Details on GLP-1 Pill Decisions
Hims & Hers disclosed its fourth‑quarter earnings and announced that it has withdrawn the controversial GLP‑1 weight‑loss pill it briefly launched. The decision followed conversations with key ecosystem stakeholders, including regulators and partner pharmacies. The company highlighted modest revenue growth...
InnoScot Issues Call for Early-Stage Innovations Around Patient Care, Efficiency, Workforce, and Transformation
InnoScot Health has launched a call for early‑stage innovators—including final‑year trainees, first‑year practitioners, SMEs and student entrepreneurs—to submit ideas that improve patient care, efficiency, workforce wellbeing, or enable data‑driven remote care. Successful applicants will receive a support package covering intellectual‑property...
FDA Approves Allurion’s PMA Application for Gastric Balloon System
Allurion received FDA clearance for its Gastric Balloon System featuring the Smart Capsule, a swallow‑able, endoscopy‑free obesity treatment. The capsule is placed during a 15‑minute office visit, inflates in the stomach for about four months, then exits naturally, with a...
Combining Soft and Hard Properties: Synergistic Innovation of Magnetic Hydrogel Microrobots in Precision Medicine
Magnetic hydrogel microrobots (MHMs) are emerging untethered soft robots that combine magnetic actuation with responsive hydrogel matrices. Recent research highlights dual design strategies that integrate material optimization and functional integration, enabling precise, spatiotemporal control. Innovations in bionic structures and multimodal...
CMS Updates MIPS for 2026: Administrative Claims, TEFCA Bonuses, and AI Safety Measures
CMS released its 2026 Merit‑based Incentive Payment System updates, adding administrative claims scoring, a TEFCA participation bonus, and a new AI safety measure. The changes affect quality, interoperability, improvement activities, and cost categories, with retroactive application to 2025 for large...
Assessing Targeted HIV and Harm Reduction Services
A new NIH‑backed assessment of targeted HIV prevention and harm‑reduction services in five major U.S. cities shows a 15% decline in new infections over the past year. The study attributes the drop to expanded syringe‑exchange programs, mobile testing units, and...
Cut Down on Oncology Drug Waste With Better Forecasting
Oncology drug waste reaches up to 30%, costing over $2 billion annually in the U.S. A 2023 CMS rule now forces manufacturers to refund Medicare for discarded volumes beyond a 10% threshold, adding financial pressure. Traditional forecasting relies on static sales...
Tech Alone Won’t Save UK Healthcare – Finn Stevenson, Flok Health
Finn Stevenson, CEO of AI‑driven physiotherapy startup Flok Health, discussed on the UKTN Podcast how slow reform in the NHS hampers patient care, especially for back‑pain sufferers. He highlighted Flok's hybrid model that combines algorithmic triage with live physiotherapist sessions...
Radiopharmaceutical Sector Shapes Supply Chain Around Fast-Decaying Products
Radiopharmaceutical manufacturers must design ultra‑fast supply chains because isotopes decay rapidly, turning each dose into a ticking clock. Companies such as NorthStar and Nucleus mitigate this by locating production near major airports, using private air freight for longer‑half‑life isotopes, and...
Drug Surveillance Systems and the Challenge of Powerful New Opioids
Emerging synthetic opioid cychlorphine, up to ten times more potent than fentanyl, has been linked to fatal overdoses across the United States, Canada, the United Kingdom, France, and Germany. Tennessee alone reports 19 deaths under investigation, with 12 confirmed, while...
Drug-Controlled CAR T Cells May Enable Safer Immunotherapy
Researchers at EPFL have created a drug‑controlled CAR‑T platform called DROP‑CAR that can be turned off on demand with the FDA‑approved BCL‑2 inhibitor venetoclax. The system places a reversible protein‑protein interaction on the cell surface, causing the CAR to dissociate...
GPs to Get £3,000 Bonus to Maximise Weight Loss Drug Prescriptions
The UK government will add a £3,000 average annual bonus to GP contracts for prescribing the weight‑loss drug Mounjaro, plus a £1,000 incentive for referrals to weight‑loss programmes, starting in April 2026. The scheme targets patients who meet current NHS...
System Isolates Single Extracellular Vesicle Surface Proteins to Map Function
UC Davis engineers unveiled VESSEL, a cell‑free platform that produces extracellular vesicles bearing a single surface protein. By isolating individual proteins, the system enables direct functional mapping, exemplified by the discovery that CADM1 promotes vesicle uptake. The approach is scalable...
Cytokinetics Inc (CYTK) Q4 2025 Earnings Call Transcript
Cytokinetics announced rapid global regulatory clearance for MYCorzo, securing FDA, China NMPA, and European Commission approvals within a single week. The company launched the drug in the U.S. with over 700 REMS‑certified physicians and more than 12,000 customer engagements in...
Standard BioTools Inc (LAB) Q4 2025 Earnings Call Transcript
Pacific Biosciences reported Q4 2025 revenue of $44.6 million, a 14% year‑over‑year increase, driven by record consumable sales and higher Vega system placements. Consumables generated $21.6 million, up 15% YoY, pushing non‑GAAP gross margin to 40% for the quarter and the full...
Orthofix Medical Inc (OFIX) Q4 2025 Earnings Call Transcript
Orthofix Medical reported fourth‑quarter 2020 net sales of $118 million, a 3% decline year‑over‑year but a 6% sequential increase. Spine implant revenue grew 9% YoY, propelled by an 11% rise in U.S. M6 disc sales, while motion‑preservation revenue jumped 129% YoY....
CareDx Inc (CDNA) Q4 2025 Earnings Call Transcript
CareDx reported Q4 2025 revenue of $108.4 million, up 25% year‑over‑year, propelled by testing services and a 47% surge in patient‑digital solutions. Adjusted EBITDA fell 34% because of a $6.7 million one‑time executive bonus, while cash balances reached $201 million and the company...
BridgeBio Pharma Inc (BBIO) Q4 2025 Earnings Call Transcript
BridgeBio Pharma reported Q4 2025 revenue of $120.7 million, a surge driven primarily by Attruby net product sales of $108.1 million and expanding royalty streams. The company announced statistically significant Phase III readouts for BBP-418 in limb‑girdle muscular dystrophy and...
Harmony Biosciences Holdings Inc (HRMY) Q4 2025 Earnings Call Transcript
Harmony Biosciences reported $714.7 million net product revenue for 2024, a 23% year‑over‑year increase, with Q4 sales of $201.3 million driven largely by its flagship narcolepsy drug Wakix. The company announced a generic settlement with Novogen that postpones competition until at least...
Avanos Medical Inc (AVNS) Q4 2025 Earnings Call Transcript
Avanos Medical reported $178 million net sales for the quarter, with organic sales in its strategic segments rising 10% year‑over‑year. The Specialty Nutrition Systems segment posted 14.5% organic growth, while the radiofrequency ablation business achieved double‑digit expansion. The company completed the...
Establishment Labs Holdings Inc (ESTA) Q4 2025 Earnings Call Transcript
Establishment Labs reported $53.8 million revenue for Q3 2025, a 33.7% year‑over‑year increase, and achieved a 70.1% gross profit margin, the first time surpassing the 70% benchmark. The company posted its inaugural positive adjusted EBITDA of $1.2 million, reversing losses of...
Vaxcyte Inc (PCVX) Q4 2025 Earnings Call Transcript
Incyte reported a strong Q4 2025, delivering $1.51 billion in revenue, a 28% year‑over‑year increase, and $5.14 billion for the full year, up 21%. Core products drove the surge: Jakafi posted $828 million in Q4 sales, Opsilura $207 million, and hematology/oncology sales jumped 121%...
Abcellera Biologics Inc (ABCL) Q4 2025 Earnings Call Transcript
AbCellera Biologics reported a transformative 2024, shifting from a partnership platform to a clinical‑stage biotech. The company advanced two internal antibody programs, ABCL635 and ABCL575, toward CTA filings in Q2 2025 and highlighted a $800 million liquidity position. It outlined a...
Henry Schein Inc (HSIC) Q4 2025 Earnings Call Transcript
Henry Schein reported $3.4 billion in Q4 2025 sales, a 7.7% increase and the strongest growth in over three years. Non‑GAAP operating margin held at 7.42% while cash flow from operations jumped to $381 million. Cloud‑based Dentrix Ascend reached over 11,000 subscribers,...
Iovance Biotherapeutics Inc (IOVA) Q4 2025 Earnings Call Transcript
Iovance Biotherapeutics reported third‑quarter product revenue of about $68 million, a 13% sequential increase, driven primarily by $58 million in Amtagvi sales and $10 million in Proleukin revenue. Gross margin improved to roughly 43% after a restructuring that cut cost of sales by...
Fulcrum Therapeutics Inc (FULC) Q4 2025 Earnings Call Transcript
Fulcrum Therapeutics reported a strong fourth‑quarter, posting $1.51 billion in revenue, a 28% year‑over‑year increase, and a full‑year 2025 revenue of $5.14 billion, up 21%. Core product sales accelerated, led by Jakafi’s $828 million Q4 revenue and Opsilura’s 28% sales jump to $207 million....
Adapthealth Corp (AHCO) Q4 2025 Earnings Call Transcript
American Well Corp (AHCO) reported Q4 2025 revenue of $55.3 million, a 22.1% YoY decline, as the company completed its pivot from a multi‑product telehealth provider to a pure SaaS platform. Subscription revenue now represents 53% of total revenue, reflecting...
Supernus Pharmaceuticals Inc (SUPN) Q4 2025 Earnings Call Transcript
Vanda Pharmaceuticals reported a 9% rise in total revenue to $216.1 million for 2025, driven primarily by a 24% jump in Fanapt sales and a successful bipolar disorder launch. The company secured FDA approval for tradipitant (Nirius) for motion‑sickness prevention, marking...
Option Care Health Inc (OPCH) Q4 2025 Earnings Call Transcript
Centene reported full‑year 2025 adjusted diluted EPS of $2.08 and a Q4 loss of $1.19 per share, impacted by a $389 million Magellan divestiture charge. Management forecast 2026 adjusted EPS above $3, implying more than 40% year‑over‑year growth, driven by Medicaid...
Globus Medical Inc (GMED) Q4 2025 Earnings Call Transcript
Globus Medical reported a record $2.519 billion revenue for 2024, up 61% year‑over‑year, and a non‑GAAP EPS of $3.04, a 31% increase. Free cash flow surged 145% to $405 million, allowing the company to eliminate its remaining $1 billion merger debt by Q1 2025....
Evolent Health Inc (EVH) Q4 2025 Earnings Call Transcript
Evolent Health reported $2.55 billion in 2024 revenue, a 30% year‑over‑year increase, with adjusted EBITDA of $160.5 million landing at the low end of its guidance due to elevated oncology costs. The company announced two major contracts—a New England health plan covering...
Ceribell Inc (CBLL) Q4 2025 Earnings Call Transcript
Ceribell reported a 34% year‑over‑year revenue increase to $24.8 million in Q4 2025, reaching $89.1 million for the full year. Gross margins remained high at 87% for the quarter, with a cash balance of $159.3 million, while net loss widened to $13.5 million due...
![[Correspondence] Internet Shutdowns in Iran and the Right to Health](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/69e5c876c0c0e081e3156d4b1214d794.webp)
[Correspondence] Internet Shutdowns in Iran and the Right to Health
In January 2026 Iran imposed a nationwide internet blackout that remains heavily filtered, coinciding with a violent crackdown on protesters and attacks on hospitals. The shutdown has crippled emergency medical coordination, tele‑medicine, and public‑health reporting, contributing to thousands of preventable...
![[Correspondence] Student Suicide Risk and Counselling in the Kurdistan Region of Iraq](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/17d1d078e9209eeedbbafde30ade8668.webp)
[Correspondence] Student Suicide Risk and Counselling in the Kurdistan Region of Iraq
A growing body of evidence shows that suicide and related behaviors are increasingly common among medical students worldwide, posing a serious challenge for education systems. The issue is especially acute in the Kurdistan Region of Iraq, where chronic crises exacerbate...
India Expands Digital Health Impact Domestically and Globally
India reaffirmed its commitment to digital health at the IGSTC Strategic Conclave 2026, spotlighting telemedicine advancements for the Armed Forces and the broader public. The event announced expanded collaboration with Germany and highlighted the integration of telehealth into the Ayushman...
Android Mental Health Apps with 14.7M Installs Filled with Security Flaws
Security firm Oversecured scanned ten Android mental‑health apps with more than 14.7 million combined installs and uncovered 1,575 vulnerabilities. The flaws include 54 high‑severity and 538 medium‑severity issues such as insecure intent handling, plaintext API keys, and weak random number generation....
Animal Muscles Inspire Biomaterial Design for Agriculture, Fabrics and Medicine
Researchers at Washington University in St. Louis have engineered muscle‑inspired protein fibers using synthetic biology, creating filamin‑based threads that combine high tensile strength, toughness, damping and shape‑memory. By growing genetically modified microbes in bioreactors, they achieved higher protein yields and...
Skilled Nursing Dealbook: 280 Beds Realigned in Ohio as 80-Bed Nebraska Nursing Home Changes Hands
Senwell Senior Investment Advisors completed a multi‑party realignment of more than 280 skilled‑nursing beds across Ohio, moving capacity from overbedded counties to operators targeting high‑demand markets. The transaction involved 12 unnamed sellers and multiple buyers seeking growth or new facility...
Care.com and Headspace Launch Mental Health Partnership for Caregivers
Care.com and Headspace announced a partnership to bolster mental‑health support for family caregivers. The collaboration introduces ten exclusive micro‑mindfulness videos, each under three minutes, and provides free Headspace subscriptions to Care.com members. The initiative responds to data showing roughly one‑third...
Accelerating Next Generation Medicine with New Drug Delivery Platform
Scientists at the University of Nottingham have unveiled a modular materials platform that self‑assembles with RNA to form nanoscale delivery particles. The system uses reversible host‑guest linkages, allowing rapid tuning of stability and behavior for diverse therapeutic needs. In pre‑clinical...
Worsening CAC Tied to Cognitive Decline in Midlife: CARDIA
A new analysis of the CARDIA cohort shows that progression of coronary artery calcium (CAC) over roughly a decade is linked to measurable declines in processing speed and global cognition among middle‑aged adults. The relationship holds regardless of baseline CAC...